{"id":"conventional-antithrombotic-strategy","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding"},{"rate":null,"effect":"Gastrointestinal hemorrhage"},{"rate":null,"effect":"Intracranial hemorrhage"},{"rate":null,"effect":"Thrombocytopenia"}]},"_chembl":{"chemblId":"CHEMBL1201202","moleculeType":"Oligosaccharide","molecularWeight":"1508.27"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This represents a standard clinical approach using established antithrombotic medications such as aspirin, clopidogrel, warfarin, or heparins to inhibit platelet aggregation or coagulation cascade activation. The strategy is used to prevent arterial and venous thromboembolism in patients at risk for myocardial infarction, stroke, or deep vein thrombosis.","oneSentence":"Conventional antithrombotic strategy prevents blood clot formation through antiplatelet and/or anticoagulant agents to reduce thrombotic events.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:31:08.071Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome"},{"name":"Atrial fibrillation for stroke prevention"},{"name":"Venous thromboembolism prophylaxis and treatment"},{"name":"Peripheral arterial disease"}]},"trialDetails":[{"nctId":"NCT03465644","phase":"PHASE4","title":"TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI","status":"COMPLETED","sponsor":"Duk-Woo Park, MD","startDate":"2019-02-12","conditions":"Coronary Stenoses","enrollment":2018},{"nctId":"NCT06084000","phase":"NA","title":"STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial","status":"UNKNOWN","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2023-10-15","conditions":"Drug-coated Balloon, Drug-eluting Stent, De Novo Stenosis","enrollment":2700},{"nctId":"NCT04619927","phase":"PHASE4","title":"Genotype-guided Strategy for Antithrombotic Treatment in Peripheral Arterial Disease.","status":"UNKNOWN","sponsor":"Radboud University Medical Center","startDate":"2021-03-01","conditions":"Peripheral Arterial Disease","enrollment":2276},{"nctId":"NCT01586702","phase":"NA","title":"Intensified Secondary Prevention Intending a Reduction of Recurrent Events in TIA and Minor Stroke Patients","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2011-09","conditions":"Mini-Stroke","enrollment":2082},{"nctId":"NCT01108692","phase":"NA","title":"Strategy of Early Detection and Active Management of Supraventricular Arrhythmia With Telecardiology (SETAM)","status":"COMPLETED","sponsor":"Biotronik France","startDate":"2010-07","conditions":"Atrial Fibrillation, Atrial Flutter, Atrial Tachycardia","enrollment":602}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":10,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Conventional antithrombotic strategy","genericName":"Conventional antithrombotic strategy","companyName":"Duk-Woo Park, MD","companyId":"duk-woo-park-md","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Conventional antithrombotic strategy involves the use of standard dual antiplatelet therapy. The modality of conventional antithrombotic strategy is not specified, but it is known to be used in conditions such as coronary stenoses, atrial fibrillation, atrial flutter, atrial tachycardia, and mini-stroke.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}